Common variants of DNA repair genes and malignant melanoma

European Journal of Cancer

Volumn 44, Issue 1, 2008, Pages 110-114

  Debniak, T ^a   Scott, R J ^b   Gorski B ^a   Cybulski, C ^a   van de Wetering, T ^a   Serrano Fernandez, P ^a   Huzarski, T ^a   Byrski, T ^a   Nagay, L ^c   Debniak, B ^d   Kowalska, E ^a   Jakubowska, A ^a   Gronwald, J ^a   Wokolorczyk, D ^a   Maleszka, R ^a   Kladny J ^a   Lubinski, J ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c Regional Hospital   (Poland)

^d Regional Hospital   (Poland)

Author keywords

BRCA2; CHEK2; Malignant melanoma

Indexed keywords

ADULT; ARTICLE; BRCA2 GENE; CANCER RISK; CELL CYCLE REGULATION; CHEK2 GENE; CONTROLLED STUDY; DNA REPAIR; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; ONCOGENE; PRIORITY JOURNAL;

CASE-CONTROL STUDIES; DNA REPAIR; FEMALE; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MUTATION; PEDIGREE; POLYMERASE CHAIN REACTION; PROTEIN-SERINE-THREONINE KINASES; SKIN NEOPLASMS;

EID: 37149000722     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.10.006     Document Type: Article

References (18)

1. The Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortum. J Natl Cancer Inst 1999;91:1310-s6.
2. Scott R.J., Vajdic C.M., Armstrong B.K., et al. BRCA2 mutations in a population-based series of patients with ocular melanoma. Int J Cancer 102 (2002) 188-191
3. Debniak T., Gorski B., Cybulski C., et al. Rarity of germline 1100delC mutation in CHK2 in patients with malignant melanoma of the skin. Melanoma Res 14 (2004) 121-124
4. Gorski B., Narod S.A., and Lubinski J. A common missense variant in BRCA2 predisposes to early onset breast cancer. Breast Cancer Res 7 (2005) 1023-1027
5. García-Closas M., Egan K.M., Newcomb P.A., et al. Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum Genet 119 (2006) 376-388
6. Cybulski C., Wokolorczyk D., Kladny J., et al. Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?. Eur J Hum Genet 15 (2007) 237-241
7. Ott J. Utility programs for analyisis of genetic linkage; Program HWE. , 1988.
8. Carter K.W., McCaskie P.A., and Palmer L.J. A Java based linkage disequilibrium plotter. BMC Bioinformat 7 (2006) 60
9. Hearle N., Damato B.E., Humphreys J., et al. Contribution of germline mutations in BRCA2, P16(INK4A), P14(ARF) and P15 to uveal melanoma. Invest Ophthalmol Vis Sci 44 (2003) 458-462
10. Iscovich J., Abdulrazik M., Cour C., Fischbein A., Pe'er J., and Goldgar D.E. Prevalence of the BRCA2 6174 del T mutation in Israeli uveal melanoma patients. Int J Cancer 98 (2002) 42-44
11. Sinilnikova O.M., Egan K.M., Quinn J.L., et al. Germline brca2 sequence variants in patients with ocular melanoma. Int J Cancer 82 (1999) 325-328
12. Casula M., Colombino M., Satta M.P., et al. Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South Italy. Eur J Cancer 43 (2007) 137-143
13. Cybulski C., Gorski B., Huzarski T., et al. CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet 75 (2004) 1131-1135
14. Hashemi J., Platz A., Ueno T., Stierner U., Ringborg U., and Hansson J. CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas. Cancer Res 60 (2000) 6864-6867
15. Palmer J.S., Duffy D.L., Box N.F., et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?. Am J Hum Genet 66 (2000) 176-186
16. Debniak T., Scott R., Masojc B., et al. MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk. Int J Cancer 119 (2006) 2597-2602
17. Li C., Hu Z., Liu Z., et al. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis. Cancer Epidemiol Biomarkers Prev 15 (2006) 2526-2532
18. Han J., Colditz G.A., Liu J.S., and Hunter D.J. Genetic variation in XPD, sun exposure, and risk of skin cancer. Cancer Epidemiol Biomarkers Prev 14 (2005) 1539-1544